2021 Abstracts

2021 Call for Abstracts

Important Dates

Abstract Submission Deadline............................22 March 2021 at 16:00 CET

Abstract Notifications Mailed...............................16 April 2021

Abstract Withdrawal Deadline.............................26 April 2021

Abstract Presenter Registration Deadline............6 May 2021

Late-Breaking Abstract Deadline.........................13 June 2021

2021 Abstract Submission is Now Open

The 23rd ESMO World Congress on Gastrointestinal Cancer is now accepting abstracts in the following categories. Click here to submit your abstract.

Abstract Categories

Colon Cancer

Esophageal Cancer

Gastric Cancer

Hepatocellular Carcinoma

Pancreatic Cancer

Rectal Cancer

Biliary Tract Cancer

Neuroendocrine Tumors

Others (including GIST and Anal Cancer)

Abstract Guidelines

  • Follow the online instructions

  • Abstracts must be written in English

  • The submitted work must not, nor will not have been:
    • published in any journal, or on any web site before 30 June 2021, nor

    • presented at any national or international scientific conference prior to 30 June 2021

    • Encore abstracts will be allowed if they contain new data. During the submission process you will be asked whether the abstract has been presented before, when you say yes you will be prompted to submit the original abstract as a reference.

  • Abstract body must not exceed 500 words

  • Use a concise title

  • List affiliations of author(s) as briefly as possible, with city, province/state and country

  • Use standard and well-accepted abbreviations

  • When using references, use standard and well-accepted formats

  • Abstract content should be single-spaced and typed in lower case

  • Abstracts shall be of original research and contain a concise statement of study aim

  • Submit four (4) parts of your abstract: Background, Method, Results, and Conclusion(s). Conclusions must be supported by your results and summarized within your abstract at the time of submission. Results “to be completed” and/or conclusions “to be discussed” are not acceptable.

Trials in Progress Abstract Submissions

We are now accepting Trials in Progress abstract submissions in all phases of clinical research (phase I to phase III). All abstracts submitted as Trials in Progress are ongoing trials that have not reached any protocol-specific endpoint for analysis and will only require the completion of two sections: Background and Trial Design. It is a requirement that recruitment must have already begun or have been completed by the abstract submission deadline.

Late-Breaking Abstract Submissions

The Congress late-breaking policy allows the submission of late-breaking abstracts defined as “high quality, new research findings from randomized phase II or phase III trials with implications for clinical practice or understanding of disease processes.”

An abstract template should be submitted by the regular abstract deadline (22 March 2021 at 16:00 CET). The template should include: title, author list, and a description of the study. A final abstract version must be submitted by 13 June, 2021 and will be published in a supplement of the Annals of Oncology.

 

2021 Developing Nations Travel Awards

A limited number of travel awards are available for investigators from developing nations. Awards are available to investigators from the countries indicated in the 2021 World Bank List of Economies as Low, Lower Middle or Upper Middle Income Economies. The complete list can be found at http://www.worldbank.org

The winners will be awarded free registration to the Congress.

How to Apply for Developing Nations Travel Awards:

  • The candidate must submit an abstract to the ESMO 23rd World Congress on Gastrointestinal Cancer in the usual manner, indicating that the abstract is to be considered for the Developing Nations Award
  • The candidate must be the first author of the submitted abstract
  • The work must not have been presented or published before the date of the ESMO 23rd World Congress on Gastrointestinal Cancer
  • Abstracts must be submitted on schedule
  • Candidates should submit:
    • A Curriculum Vitae
    • A 1-3 page description of their interests and current research in gastrointestinal cancer signed and approved by their department chair

The Scientific Committee will select the award winners on the basis of the scientific content of the abstract. Winners will be notified in April 2021.

Young Investigator Best Abstract Awards

A limited number of Young Investigator Best Abstract Awards are available, upon application, to first author (= presenter) to candidates under the age of 35 who submit abstracts considered deserving of recognition.

The winners will be awarded free registration to the Congress.

How do I apply for a young investigator award?

  • The candidate must submit an abstract to the ESMO 23rd World Congress on Gastrointestinal Cancer in the usual manner, indicating that the abstract is to be considered for the Young Investigator Award during submission.
  • To be considered for the Young Investigator Award, candidates will be required to submit a brief summary (cannot exceed 500 words) of the findings of the abstract and their relevance to the topics presented at the Congress.
  • The age if the candidate should be less than 35 years of age by the submission deadline (Age will be verified).
  • The candidate must be the first and presenting author of the submitted abstract.
  • The work must not have been presented or published before the date of the ESMO 23rd World Congress on Gastrointestinal Cancer.

The Scientific Committee will select the award winners on the basis of the scientific content of the abstract. Winners will be notified in April 2021.

Registration

All abstract presenters should be registered for the meeting.